Attending #ASCO24? The Sapience team is excited to share that we will present new clinical and biomarker data from our ST101 Phase 2 study in glioblastoma during an oral presentation at #ASCO24. Learn more here: https://lnkd.in/gcX-zh-d #ASCO24 #Oncology #Glioblastoma #GBM Abi Vainstein-Haras
Hello Dana, I have missed working with you and happy to see that you are working for Sapience and GBM. My mother passed 25 years ago from GBM at a time when treatments were NOT promising. Thank you to Sapience for fighting GBM!
GBM is devastating
Business Development Manager at Euromed Pharma
1moWe would love to work with you on your drug sourcing for your upcoming ph2b trials for ST101. Would you be available to chat next week?